Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Figure out How to Amplify the Resale Worth of Your Kona SUV - 2Winter solstice 2025 marks the shortest day of the year in the Northern Hemisphere today
- 3Germany's first Omani LNG shipments arrive despite Middle East disruptions
- 4Intriguing Strange Cruising Objections you Should Visit
- 5At least 490 protesters killed in Iran, activists say
- Closets for Your Room: Plan and Utility Features
- Invigorating Spots To Go Kayaking All over The Planet
- Kuwait is softening stance on Israel, dissident tells ‘Post’ after viral UN speech
- Activists guilty over Palestine protest breach
- Nature's Treats: 10 Organic products That Lift Prosperity
- Explainer-Why are hepatitis B vaccines given to newborns?
- The newest 'Project Hail Mary' trailer shows Ryan Gosling befriending an alien in Phil Lord and Chris Miller's space epic
- Famous Versatile Brands: Your Decision
- The most effective method to Decisively Plan Your Nursing Profession for the Best Compensation Results
